🔎 Trials Near Me

Home › Medulloblastoma › District of Columbia › Washington

Medulloblastoma clinical trials in Washington, DC

9 studies for Medulloblastoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

RecruitingPhase 1/2
  • Children's National Hospital, Washington D.C.
Ages 1 to 25 · All sexes · Updated Sep 28, 2026 · NCT07346157

Digoxin Medulloblastoma Study

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

RecruitingPhase 3
  • Children's National Medical Center, Washington D.C.
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

RecruitingPhase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 120 · All sexes · Updated Aug 12, 2026 · NCT06161519

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Recruiting
  • Children's National Hospital, Washington D.C.
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

RecruitingPhase 1
  • Children's National Hospital, Washington D.C.
Ages 4 to 30 · All sexes · Updated Aug 7, 2026 · NCT06514898

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

RecruitingPhase 1
  • Children's National Hospital, Washington D.C.
Ages 1 to 30 · All sexes · Updated Jun 17, 2026 · NCT06193759

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

RecruitingPhase 1
  • National Institutes of Health, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082

Medulloblastoma trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.